ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic.

Jason D GoldmanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.